The UK is witnessing a burgeoning interest in mind-altering compounds , particularly copyright and Cannabigerol . Scientists are progressively copyrightining the possibilities of these chemicals for therapeutic purposes, resulting in a nuanced dialogue around their regulatory standing and safe integra